Profile
Samuel Hochstrasser’s practice focuses on domestic and cross-border M&A, capital markets and private equity transactions. His expertise includes corporate, commercial and contract law. He has particular knowledge of the life sciences sector, advising on regulatory and legal in life science matters.
Deals & Cases
Practice Areas
Experience
Select Menu
Recent matters in which Samuel acted as counsel include:
- Landis+Gyr Group and its shareholders Toshiba and INCJ in the dual track exit process resulting in the CHF 2.3 billion IPO of Landis+Gyr Group on SIX, the largest Swiss IPO of the past 10 years and second largest IPO in Europe 2017
- Actelion in connection with the public tender offer by Johnson & Johnson to the shareholders of Actelion and in connection with the demerger of Idorsia from Actelion
- BioTelemetry, Inc. in connection with its competing public tender offer to the shareholders of LifeWatch AG
2020
LL.M., Keio University, Tokyo, Gerald P. McAlinn Price in International and Comparative Law
2016
Admitted to the Bar, Rechtsanwalt
2014
University of St. Gallen, Master of Arts HSG in Law and Economics
2012
University of Texas, School of Law, Exchange Semester
2011
University of St. Gallen, Bachelor of Arts HSG in Law and Economics
- Swiss Bar Association
- Zurich Bar Association
- HSG Alumni
2022
Senior Associate, Niederer Kraft Frey
2017
Associate, Niederer Kraft Frey
2015
Clerk with the District Court of Aarau
2014
Junior Associate, Niederer Kraft Frey
German
English
French